Indusken Pharmaceuticals Private Limited

Founded in 2003 and headquartered in Maharashtra, India.

2003 | Thane, Maharashtra (India) | Active
Last Updated:

Indusken Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 4.00 M
  • Paid Up Capital ₹ 2.52 M
  • Company Age 22 Year, 4 Months
  • Last Filing with ROC 31 Mar 2013
  • Open Charges ₹ 1.20 M

About Indusken Pharmaceuticals

Indusken Pharmaceuticals Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 February 2003 and has a history of 22 years and four months. Its registered office is in Thane, Maharashtra, India.

The Company is engaged in the Chemicals Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.52 M.

The company currently has active open charges totaling ₹1.20 M.

Narendra Deshmukh and Anjani Deshmukh serve as directors at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230MH2003PTC139032

  • Company No.

    139032

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    05 Feb 2003

  • Date of AGM

    30 Sep 2013

  • Date of Balance Sheet

    31 Mar 2013

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Chemicals
Pharmaceuticals
Company report

Indusken Pharmaceuticals Private Limited

Explore comprehensive data for Indusken Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Indusken Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Narendra Deshmukh Country flag representing In Managing Director05-Feb-2003Current

Board Members (1)

NameDesignationAppointment DateStatus
Anjani Deshmukh Country flag representing In Director 23-Feb-2006Current

Financial Performance of Indusken Pharmaceuticals.

Enhance accessibility to Indusken Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Indusken Pharmaceuticals revenue growth over time
Indusken Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Indusken Pharmaceuticals?

Unlock access to Indusken Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹1.20 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Bank Of Maharashtra : 0.12 Cr

Latest Charge Details

DateLenderAmountStatus
27 Nov 2003Bank Of Maharashtra₹1.20 MOpen

How Many Employees Work at Indusken Pharmaceuticals?

Indusken Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Indusken Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Indusken Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indusken Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Indusken Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Indusken Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records.

  • Balance Sheet

    Indusken Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai.

  • Director Appointment

    Anjani Narendra Deshmukh was appointed as a Director was appointed as a Director on 23 Feb 2006 & has been associated with this company since 19 years 3 months .

  • Charges

    A charge with Bank Of Maharashtra of Rs. 1.20 M registered on 27 Nov 2003 with Charge ID 90148475 was modified on 27 May 2004.

  • Charges

    A charge with Bank Of Maharashtra amounted to Rs. 1.20 M with Charge ID 90148475 was registered on 27 Nov 2003.

  • Director Appointment

    Narendra Damodar Deshmukh was appointed as a Managing Director was appointed as a Managing Director on 05 Feb 2003 & has been associated with this company since 22 years 4 months .

Frequently asked questions

  • What is the Incorporation or founding date of Indusken Pharmaceuticals Private Limited?

    Indusken Pharmaceuticals Private Limited was incorporated on 05 Feb 2003.

  • What is authorized share capital and paid-up capital of Indusken Pharmaceuticals Private Limited?

    The authorized share capital of Indusken Pharmaceuticals Private Limited is ₹ 4.00 M and paid-up capital is ₹ 2.52 M.

  • Who are the current board members & directors of Indusken Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Indusken Pharmaceuticals Private Limited.

    • Narendra Damodar Deshmukh
    • Anjani Narendra Deshmukh

  • What is the registered address of Indusken Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Indusken Pharmaceuticals Private Limited is 6 Sangeeta Industrial Estate 1St Floor Pokhran Road No.1, West India, Thane, Maharashtra, 400606.

  • What is the corporate identification number (CIN) and company number of Indusken Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Indusken Pharmaceuticals Private Limited is U24230MH2003PTC139032 and the company number is 139032 as per Ministry of Corporate Affairs (MCA).

  • What are the total open charges for Indusken Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 0, The total open charges for Indusken Pharmaceuticals Private Limited amount to ₹ 1.20 M.

  • When was the last Balance Sheet of Indusken Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Indusken Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2013.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Medicinal Chemicals And Botanical Products